CLINICAL_TRIALS
withdrawal
· 2015-11-17
Clinical Trial Update: A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome [Phase 3]
Summary
Phase 3 randomized, double-blind, placebo-controlled trial of L-carnitine and Piracetam for weakness and muscle fatigue in post-polio syndrome has been withdraw…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biolab Sanus Farmaceutica | Conditions: Postpoliomyelitis Syndrome | Phase 3 | Status: WITHDRAWN